Skip to Content
Morningstar

Vanguard PRIMECAP Core Inv VPCCX

Morningstar Medalist Rating
Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 36.19  /  +0.19 %
  • Total Assets 13.2 Bil
  • Adj. Expense Ratio
    0.460%
  • Expense Ratio 0.460%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 3,000
  • Status Open
  • TTM Yield 1.07%
  • Turnover 6%

USD | NAV as of Jul 05, 2024 | 1-Day Return as of Jul 05, 2024, 10:22 PM GMT+0

Morningstar’s Analysis VPCCX

Will VPCCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable VPCCX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the VPCCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of VPCCX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Still strong after a middling half-decade.

Strategist Robby Greengold

Robby Greengold

Strategist

Summary

We have qualitatively reviewed this strategy and reaffirmed its Process and People ratings. Vanguard Primecap Core stands out for its seasoned management and high-conviction multimanager system. The remainder of this analysis is from July 7, 2023.

by Robby Greengold
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VPCCX

More VPCCX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 33.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

10.59 1.4 Bil
Healthcare

Mktliq 12/31/2049

3.56 468.3 Mil
Cash and Equivalents

Microsoft Corp

3.17 416.5 Mil
Technology

KLA Corp

2.94 387.3 Mil
Technology

Amgen Inc

2.92 384.1 Mil
Healthcare

AstraZeneca PLC ADR

2.88 378.5 Mil
Healthcare

Intel Corp

2.65 349.0 Mil
Technology

Siemens AG

2.14 280.9 Mil
Industrials

Biogen Inc

2.13 279.9 Mil
Healthcare

FedEx Corp

2.05 269.7 Mil
Industrials